Anwar R. Padhani on Muck Rack

Anwar R. Padhani

England
As seen in: Color Research & Application, Nature, JAMA Oncology, Medscape, Radiological Society of North America, Health Service Journal, European Urology, European Urology Oncology, UroToday
Oncologic Radiologist @ScannerCentre Mount Vernon Cancer Center UK | Professor @ICR_London | Trustee @ICIS_NEWS | Co-Chair #PIRADS Committee
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Anwar R.

Contact Anwar R., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Prostate Imaging Standards for Screening Magnetic Resonance Imaging (PRISM) : International Consensus Recommendations

|
By Nikhil Mayor, Alexander Light, Archana Gopalakrishnan, Emma Cullen, Natasha Thorley, Tristan Barrett, Tim Dudderidge, Mark Emberton, Francesco Giganti, Aiman Haider, Masoom A. Haider, Amish Lakhani, Caroline Moore, Tobias Nordström, Anwar R. Padhani, Ivo G. Schoots, Andrew Smith, Henry Tam, Massimo Valerio, Sadhna Verma, Samuel J Withey, Shonit Punwani, Taimur T. Shah, Jan van der Meulen, Hashim U. Ahmed, Francesca Rawlins, Varsha Sonigra-Patel, Oliver Hulson
| JAMA Oncology Verified
Prostate Imaging Standards for Screening Magnetic Resonance Imaging (PRISM): International Consensus Recommendations Abstract Importance Magnetic resonance imaging (MRI) is routinely used in prostate cancer diagnosis, but there is uncertainty about its optimal use in population-level screening. Objective To provide consensus recommendations on the acquisition, interpretation, and reporting of prostate MRI for cancer screening.
Open in Who Shared Issue with article?

How Imaging Advances Are Defining the Future of Precision Radiation Therapy

|
By Roberto García-Figueiras, Sandra Baleato-González, Antonio Luna, Anwar R. Padhani
| Radiological Society of North America
References 1. . Contemporary radiotherapy: present and future. Lancet 2021;398(10295):171–184. Crossref, Medline, Google Scholar 2. . The oligometastatic spectrum in the era of improved detection and modern systemic therapy. Nat Rev Clin Oncol 2022;19(9):585–599. Crossref, Medline, Google Scholar 3. . Diagnostic Imaging Modalities to Assess Treatment Response of Bone Metastasis in Patients Receiving Palliative Radiotherapy: A Scoping Review of the Literature. Can Assoc Radiol J 2020;71(4):495–504.
Open in Who Shared Issue with article?

Perceived patient burden and acceptability of MRI in comparison to PSA and ultrasound: results from the IP1-PROSTAGRAM study - Prostate Cancer and Prostatic Diseases

|
By David Eldred-Evans, Mathias Winkler, Martin Connor, Anwar R. Padhani
| Nature Verified
Abstract Background The IP1-PROSTAGRAM study showed that a short, non-contrast MRI detected more significant cancers with similar rates of biopsy compared to PSA. Herein, we compare the expected and perceived burden of PSA, MRI and ultrasound as screening tests. Methods IP1-PROSTAGRAM was a prospective, population-based, paired screening study of 408 men conducted at seven UK primary care practices and two imaging centres. The screening tests were serum PSA, non-contrast MRI and ultrasound.
Open in Who Shared Issue with article?
See all 28 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified